Evidence map›Paper›PMID 34315976›Full record

ArticleScientific reports2021

Determination of the characteristic inactivation fluence for SARS-CoV-2 under UV-C radiation considering light absorption in culture media.

Juan Carlos Martínez-Antón, Alejandro Brun, Daniel Vázquez, Sandra Moreno, Antonio A Fernández-Balbuena, Javier Alda

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juan Carlos Martínez-AntónApplied Optics Complutense Group, Faculty of Optics and Optometry, University Complutense of Madrid, Av. Arcos de Jalón, 118, 28037, Madrid, Spain.
Alejandro BrunCentro de Investigación en Sanidad Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Carretera Algete-El Casar de Talamanca, Km 8.1, 28130, Valdeolmos, Madrid, Spain.
Daniel VázquezApplied Optics Complutense Group, Faculty of Optics and Optometry, University Complutense of Madrid, Av. Arcos de Jalón, 118, 28037, Madrid, Spain.
Sandra MorenoCentro de Investigación en Sanidad Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Carretera Algete-El Casar de Talamanca, Km 8.1, 28130, Valdeolmos, Madrid, Spain.
Antonio A Fernández-BalbuenaApplied Optics Complutense Group, Faculty of Optics and Optometry, University Complutense of Madrid, Av. Arcos de Jalón, 118, 28037, Madrid, Spain.
Javier AldaApplied Optics Complutense Group, Faculty of Optics and Optometry, University Complutense of Madrid, Av. Arcos de Jalón, 118, 28037, Madrid, Spain. javier.alda@ucm.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The optical absorption coefficient of culture media is critical for the survival analysis of pathogens under optical irradiation. The quality of the results obtained from experiments relies on the optical analysis of the spatial distribution of fluence which also depends on the geometry of the sample. In this contribution, we consider both the geometrical shape and the culture medium's absorption coefficient to evaluate how the spatial distribution of optical radiation affects pathogens/viruses. In this work, we exposed SARS-CoV-2 to UV-C radiation ([Formula: see text] = 254 nm) and we calculated-considering the influence of the optical absorption of the culture medium-a characteristic inactivation fluence of [Formula: see text] = 4.7 J/m

Indexed as

Absorption, RadiationCulture MediaUltraviolet RaysDisinfectionSARS-CoV-2Virus InactivationCulture Media

Identifiers

PMID34315976
PMCPMC8316444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.